IL6 and Alzheimer disease: In the postmortem AD brain, pyruvate dehydrogenase activity was noted to be impaired, and elevated levels of IL1β, TNFα, and IL6 were observed, implicating hampering of tricarboxylic acid (TCA) cycle activity due to inflammation in AD patients and mild impairment of cognition [122].